SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-15-003479
Filing Date
2015-01-21
Accepted
2015-01-20 21:17:34
Documents
1
Group Members
DR. MORANA JOVAN-EMBIRICOSF2 BIO VENTURES GP LTD.F2 BIO VENTURES V L.P.F2 BIOSCIENCE IV GP LTDF2 BIOSCIENCE VI L.P.F2 CAPITAL LTDGLOBEWAYS HOLDINGS LTD.KATHERINE PRIESTLEY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a15-2845_2sc13da.htm SC 13D/A 244733
  Complete submission text file 0001104659-15-003479.txt   246715
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139
Business Address ATTN: CHIEF FINANCIAL OFFICER 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139 617 425 9225
Radius Health, Inc. (Subject) CIK: 0001428522 (see all company filings)

IRS No.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84055 | Film No.: 15537330
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET PO BOX 309 GEORGE TOWN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET PO BOX 309 GEORGE TOWN E9 KY1-1104 617-951-8000
F2 Bioscience IV L.P. (Filed by) CIK: 0001600630 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A